Author

Xiongqun Peng

Observed name: Peng, Xiongqun

Institutions: Changsha Central Hospital, University of South China

Observed institutions: Changsha Central Hospital, Xiangya Hospital Central South University, University of South China

ORCID: 0000-0001-6769-5140

Observed ORCID: 0000-0001-6769-5140

OpenAlex ID: A5006424309

A novel role of glutathione S-transferase A3 in inhibiting hepatic stellate cell activation and rat hepatic fibrosis

2019 · Haihua Chen, Qixin Gan, et al. · Journal of Translational Medicine · 42

Fluorofenidone protects liver against inflammation and fibrosis by blocking the activation of NF‐κB pathway

2021 · Sha Tu, Yanzhi Jiang, et al. · The FASEB Journal · 22

Fluorofenidone alleviates liver fibrosis by inhibiting hepatic stellate cell autophagy via the TGF-β1/Smad pathway: implications for liver cancer

2023 · Xiongqun Peng, Huixiang Yang, et al. · PeerJ · 12

Fluorofenidone Offers Improved Renoprotection at Early Interventions during the Course of Diabetic Nephropathy in db/db Mice via Multiple Pathways

2014 · Xuan Xiong, Wenjuan Mei, et al. · PLoS ONE · 10

The Effects and Adverse Reactions of Different Bowel Cleansers on Gut Microbiota After Colonoscopy

2025 · Jiabin Hu, Xiongqun Peng, et al. · The Turkish Journal of Gastroenterology · 4

AKF-PD alleviated liver fibrosis by inducing hepatic stellate cell ferroptosis via the HIF-1α/SLC7A11 pathway

2025 · Yanrong Yi, Xiangling Tan, et al. · European journal of medical research · 3

Correction to: A novel role of glutathione S-transferase A3 in inhibiting hepatic stellate cell activation and rat hepatic fibrosis

2020 · Haihua Chen, Qixin Gan, et al. · Journal of Translational Medicine · 3

Works count: 10

Citation count: 96

H-index: 4

I10-index: 4